Moolec Science (MLEC) Non-Current Deffered Revenue (2023 - 2025)
Moolec Science's (MLEC) quarterly Non-Current Deffered Revenue came in at $1260.0 in Q2 2025, down 99.93% year-on-year from $1.9 million in Q2 2024, and down 99.96% quarter-over-quarter from $2.9 million in Q4 2024.
Moolec Science (MLEC) Non-Current Deffered Revenue (2023 - 2025) Analysis & Trends
Moolec Science has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $1260.0 for Q2 2025.
- Non-Current Deffered Revenue for Q2 2025 came in at $1260.0, down 99.93% year-over-year; the trailing twelve-month figure through Jun 2025 was $1260.0 (down 99.93% YoY), and the FY2025 annual result was $1260.0, down 99.93% from the prior year.
- Non-Current Deffered Revenue came in at $1260.0 for Q2 2025 at Moolec Science, down from $2.9 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $24.9 million in Q2 2023 to a low of $1260.0 in Q2 2025.
- The 3-year median for Non-Current Deffered Revenue is $2.4 million (2024), against an average of $7.4 million.
- Across the five-year window, Non-Current Deffered Revenue sank 92.27% in 2024 and slumped 99.93% in 2025, its largest moves.
- Moolec Science's Non-Current Deffered Revenue stood at $24.9 million in 2023, then tumbled by 88.23% to $2.9 million in 2024, then sank by 99.96% to $1260.0 in 2025.
- The last three Non-Current Deffered Revenue figures came in at $1260.0 (Q2 2025), $2.9 million (Q4 2024), and $1.9 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,260.00 |
| Dec 31, 2024 | 2.93 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Jun 30, 2023 | 24.89 Mn |